Abraxane Inventor Puts Money to Work in Sorrento
Research - On Monday, Sorrento announced that Dr. Patrick Soon-Shiong made a $41 million investment in the company and now owns 19.9% of Sorrento.
PremiumAuthor Archives: Editorial Staff
Agenus Climbs on Royalty Potential from Pharma’s New Vaccine
Insights - Agenus (AGEN) announced on Thursday that a shingles vaccine being developed by GlaxoSmithKline (GSK), and using a proprietary adjuvant licensed from AGEN, was succesful in … Continue Reading
Read now
What. A. Week. Recapping our Top Stories & Trades
Recap - In biotech investing, rarely do five trading sessions go by without some explosive volatility. This week, it was Merck’s (MRK) acquistion of Cubist Pharmaceuticals (CBST) for $9 billion, and bluebird … Continue Reading
Read now
One of the Bigger Medical Conferences is Upon Us
Recap - The American Society of Hematology’s annual meeting begins this weekend in San Francisco. It’s a big event for the oncology research community, particularly those studying blood cancers, … Continue Reading
Read nowHoliday Weeks Always Make for Weird Markets
Recap - A happy (belated) Thanksgiving to you and yours! Last week we wrote briefly about the current state of the markets, from a technical perspective. Conclusion: a short-term pull-back … Continue Reading
Read nowOne Simple Chart to Note Before Next Week
Recap - The markets have rebounded precipitously from lows this October, with both the S&P 500 and iShares NASDAQ Biotechnology Index (IBB) making new all-time highs in the … Continue Reading
Read now
In Largest Upfront Payment of its Kind, Pfizer Hooks Up with Merck KGaA
Insights - Pfizer (PFE) put up $850 million to partner with Merck KGaA on a number of immuno-oncology drugs.
Read now